Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stem cells cure tendon damage- scientists get injured equine athletes back on their hooves with pioneering stem cell therapy

02.02.2006


Researchers have unraveled the potential of stem cells in the repair and treatment of damaged tendon tissue. Royal Veterinary College (RVC) spin-out company VetCell Bioscience Ltd, set to star on the BBC 1 fly on the wall series ’SuperVets’ on Thursday 3rd of February, is helping revolutionise veterinary, and now also human, medicine through stem cell technology.



The London Bioscience Innovation Centre based spin-out set up in 2002 by business consultant Greg McGarrell, CEO of VetCell, is going from strength to strength and has now successfully treated over 300 performance horses, such as racehorses, eventers and showjumpers.

Some of the most devastating injuries and diseases of performance horses are now treatable thanks to high tech stem cell therapy. Stem cells, for the first time, offer the prospect of a return to a fully functional tendon.


In the forthcoming instalment of ’SuperVets’ Zara, a lame thoroughbred cross with a core lesion, is treated with stem cell therapy.

Like human athletes, competitive horses are vulnerable to joint injuries, especially tendon. Performance horses, like human athletes, are often pushed to their limits and this can lead to tendon or ligament injury. Injury to tendons is healed by extensive scar tissue, which limits the tendon’s normal role. The scar tissue impairs movement and is stronger than normal tendon, so does not stretch in the same way as normal tendon. In turn, this is likely lead to further lameness.

But, using the new technique to reduce the scar tissue formation caused by injury, and even regenerate damaged tendons, which is notoriously difficult in horses, can lead to complete recovery. The stem cell treatment is unique as it uses tissues to grow more tendon-like cells.

VetCell is the leading provider of stem cell technology to the world of animal health. But, VetCell scientists are now working on revolutionary treatments to speed up human biological healing processes with stem cells. It is possible that similar repair mechanisms can be instituted in humans as well. The researchers are looking at ways that the technology can be transferred to humans to treat conditions that affect tendons and ligaments such as Achilles tendonitis, a painful and often debilitating inflammation of the Achilles tendon, which can make even walking impossible.

Greg McGarrell , CEO of VetCell Bioscience Ltd, said: “VetCell is a real zero to hero biotechnology company, we’ve built it up into one of the UK’s most successful biotechnology University spin-outs on a shoe string. We have a strong management team, which means that we’ve built a powerful company without wasting a penny.

“Our success is largely due to the cutting edge research at the Royal Veterinary College being combined with the knowledge of professional city people. This means that VetCell has had a commercial focus right from the start. While universities are keen to create spin-out companies, far too few of these become successful businesses. A key problem with spin-outs is that they lack good business management.”

Jenny Murray | alfa
Further information:
http://supervets.rvc.ac.uk
http://www.communicationsmanagement.co.uk

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>